Replies to post #236208 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Look: let's say p at 200 mg was a knockout product. The P2a data would be lovely to behold and we woulda had a very big deal a long time ago. But no.

There is no way to know if 300 or 400mg will do any better or not, but 200 mg was NOT impressive at all for efficacy vs placebo

Finally we will ll find out

I think simple topline data would already be out by now if it were good news. No need for a 900 page report if larger dosing showed unequivocal benefit.